Drug maker stays close to doctors and patients

New York Times, March 17, 2008
Peter A. Kouides, MD, a hematologist at Rochester (NY) General Hospital, said he once had a patient with Gaucher disease who declined to be treated with a drug made by Genzyme. For years, Genzyme's representatives were always asking the hospital about why they were not treating the patient, he says. While most pharmaceutical makers do not even know the identities of most of the people taking their drugs, Genzyme knows virtually everyone with Gaucher disease. As a result, some critics say Genzyme influences treatment to an unusual extent and encourages the use of high doses of its drug.

MOST POPULAR

SPONSORED REPORTS
SPONSORED HEADLINES

SIGN UP

FREE e-Newsletters Join the Council Subscribe to HL magazine

SPONSORSHIP & ADVERTISING

100 Winners Circle Suite 300
Brentwood, TN 37027

800-727-5257

About | Advertise | Terms of Use | Privacy Policy | Reprints/Permissions | Contact
© HealthLeaders Media 2015 a division of BLR All rights reserved.